A new cause of intra and extrahepatic cholangitis: The drug hypersensitivity syndrome or DRESS (Drug rash with eosinophilia and systemic symptoms);Une nouvelle cause de cholangite intra et extra-hépatique: Le syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug rash with eosinophilia and systemic symptoms)

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 1, 2006, Pages 142-146

  Condat, Bertrand ^a   Zanditenas, David ^a   Collot, Véronique ^a   Legoupil, Nathalie ^a   Cazals Hatem, Dominique ^b   Hauuy, Marie Pierre ^a   Bonnet, Joëlle ^a   Ngo, Yann ^a   Roucoules, Jacques ^a   Blazquez, Martine ^a  

^a Hopital Saint Camille   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLADOL; NAPROXEN; PIROXICAM; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BILIARY TRACT DISEASE; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS; EOSINOPHILIA; FEVER; HEMATOLOGIC DISEASE; HUMAN; HUMAN HERPESVIRUS 6; INTRAHEPATIC BILE DUCT; LYMPHOCYTOSIS; MALE; VIRUS REACTIVATION;

EID: 32144435439     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73131-1     Document Type: Article

References (24)

1. Begon E, Roujeau JC. Syndrome d'hypersensibilité médicamenteuse : DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol 2004;13:293-7.
2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
3. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986;29:82-7.
4. Kaur S, Sarkar R, Thami GP, Kanwar AJ. Anticonvulsant hypersensitivity syndrome. Pediatr Dermatol 2002;19:142-5.
5. Tomecki KJ, Catalano CJ. Dapsone hypersensitivity. The sulfone syndrome revisited. Arch Dermatol 1981;117:38-9.
6. Antunes A, Davril A, Trechot P, Grandidier M, Truchetet F, Cuny JF. Syndrome d'hypersensibilité à la minocycline. Ann Dermatol Venereol 1999;126:518-21.
7. Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000;95:560-1.
8. Mitchell MC, Boitnott JK, Arregui A, Maddrey WC. Granulomatous hepatitis associated with carbamazepine therapy. Am J Med 1981;71:733-5.
9. Itha S, Kumar A, Dhingra S, Choudhuri G. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol 2003;3:21.
10. Larrey D, Michel H. Pathologie biliaire due aux médicaments. Gastroenterol Clin Biol 1993;17:H59-65.
11. Grauer L, Padilla VM, Bouza L, Barkin JS. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol 1993;88:1764-9.
12. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E. Carbamazepine-induced acute tubulointerstitial nephritis. J Pediatr 1981;98:830-2.
13. Parneix-Spake A, Bastuji-Garin S, Lobut JB, Erner J, Guyet-Rousset P, Revuz J, et al. Minocycline as a possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol 1995;131:490-1.
14. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001;285:1153-4.
15. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000;356:1587-91.
16. Eliaszewicz M, Flahault A, Roujeau JC, Fillet AM, Challine D, Mansouri S, et al. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J Am Acad Dermatol 2002;47:40-6.
17. Hashizume H, Takigawa M, Tokura Y.Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002;168:5359-68.
18. Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 1998;139:1026-32.
19. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.
20. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpes virus 6 infection as a risk factor for the developpment of severe drug-induced hypersensitivity syndrome. Arch Dermatol 2000;136:1108-12.
21. Tohyama M, Hashimoto K. Drug hypersensitivity syndrome and human herpesvirus 6 reactivation. Arch Dermatol 2002;138:268-9.
22. Tas S, Simonart T. Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An Update. Dermatology 2003;206:353-6.
23. Morand JJ, Lightburn E, Coton T, Carre D, Chouc C, Debonne JM, et al. Syndrome d'hypersensibilité médicamenteuse rapidement résolutif après perfusion d'immunoglobulines humaines. Ann Dermatol Venereol 2001;128:1351-3.
24. Beneton N, Bocquet H, Cosnes A, Revuz J, Roujeau JC. Benefit-risk assessment of acne therapies. Lancet 1997;349:1252.